Mitochondrial DNA Mutations and Pediatric Neurological Disorders: A Systematic Review
DOI:
https://doi.org/10.19166/med.v15i3.11628Keywords:
autism spectrum disorder, Leigh syndrome, mitochondrial DNA mutations, pediatric neurology, systematic reviewAbstract
Background:
Mitochondrial DNA mutations are increasingly recognized as a significant cause of neurological disease in the pediatric population, yet the breadth of genotype–phenotype associations, diagnostic yield, and clinical spectrum across different study designs and populations have not been systematically synthesized.
Methods:
A systematic search of PubMed, EMBASE, and Scopus was conducted from inception until 10 May 2026 to identify studies evaluating mitochondrial DNA mutations in pediatric patients with neurological or neurodevelopmental disorders. All authors independently performed study selection; discrepancies were resolved through discussion. Data extraction and risk-of-bias assessment were performed using standardized tools adapted for observational study designs. Narrative synthesis was conducted.
Result:
Twenty-one studies met inclusion criteria, encompassing cohort, case-control, and diagnostic studies from twelve countries. Leigh syndrome and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes were the most frequently reported phenotypes. Recurrent mutations in MT-ATP6, MT-TL1, MT-ND3, MT-ND5, and MT-ND6 were identified across studies. Autism spectrum disorder studies yielded mixed results regarding mitochondrial DNA involvement. Overall risk of bias ranged from low–moderate to high.
Conclusions:
Mitochondrial DNA mutations contribute to a wide spectrum of pediatric neurological disease, with Leigh syndrome and mitochondrial encephalomyopathy predominating. Standardized phenotyping and comprehensive sequencing approaches are needed for future multicenter studies.
References
1. Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77(5):753–759.
2. Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain. 2003;126(Pt 8):1905–1912.
3. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290(5806):457–465.
4. Falk MJ, Sondheimer N. Mitochondrial genetic diseases. Curr Opin Pediatr. 2010;22(6):711–716.
5. Saneto RP, Sedensky MM. Mitochondrial disease in childhood: mtDNA encoded. Neurotherapeutics. 2013;10(2):199–211.
6. Wortmann SB, Mayr JA, Nuoffer JM, et al. A guideline for the diagnosis of pediatric mitochondrial disease: the value of muscle and skin biopsies in the era of next-generation sequencing. Neuropediatrics. 2017;48(4):309–314.
7. Stenton SL, Prokisch H. Genetics of mitochondrial diseases: identifying mutations to help diagnosis. EBioMedicine. 2020;56:102784.
8. Rahman S. Mitochondrial disease in children. J Intern Med. 2020;287(6):609–633.
9. Thorburn DR, Rahman J, Rahman S. Mitochondrial DNA-associated Leigh syndrome and NARP. In: Adam MP, et al., eds. GeneReviews. Seattle: University of Washington; 2003 [updated 2017].
10. El-Hattab AW, Adesina AM, Jones J, et al. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116(1–2):4–12.
11. Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012;17(3):290–314.
12. Giulivi C, Zhang YF, Omanska-Klusek A, et al. Mitochondrial dysfunction in autism. JAMA. 2010;304(21):2389–2396.
13. Ardissone A, Lamantea E, Invernizzi F, et al. Phenotyping mitochondrial DNA-related diseases in childhood: a cohort study of 150 patients. Eur J Neurol. 2023;30(7):2065–2077.
14. Liu Y, Wang M, Chen W, et al. Novel pathogenic mtDNA variants in Chinese children with neurological mitochondrial disorders. Ann Clin Transl Neurol. 2025;12(3):e52315.
15. Yang X, Li J, Wang H, et al. Clinical and genetic spectrum of pediatric mitochondrial disorders in China: insights from a 47-case genetically confirmed cohort. Orphanet J Rare Dis. 2026;21(1):42.
16. Mehaney DA, Darwish RK, Elbaz RM, et al. Molecular diagnosis of mtDNA syndromes in Egyptian pediatric patients: a hospital-based study. Egypt J Med Hum Genet. 2024;25:87.
17. Lee S, Na JH, Lee YM. Epilepsy in Leigh syndrome with mitochondrial DNA mutations. Front Neurol. 2019;10:496.
18. Lee HF, Tsai CR, Chi CS, et al. Leigh syndrome in childhood: neurologic progression and functional outcome. J Clin Neurol. 2016;12(2):181–187.
19. Yu M, Zhang Z, Wang Q, et al. Clinical, neuroimaging, and pathological analyses of 13 Chinese Leigh syndrome patients with mitochondrial DNA mutations. Chin Med J (Engl). 2018;131(22):2705–2712.
20. Naess K, Freyer C, Bruhn H, et al. MtDNA mutations are a common cause of severe disease phenotypes in children with Leigh syndrome. Biochim Biophys Acta. 2009;1787(5):484–490.
21. Makino M, Horai S, Goto Y, et al. Mitochondrial DNA mutations in Leigh syndrome and their phylogenetic implications. J Hum Genet. 2000;45(2):69–75.
22. Uusimaa J, Moilanen JS, Vainionpää L, et al. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Ann Neurol. 2007;62(3):278–287.
23. Venkateswaran S, Banège L, O’Mahony J, et al. Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination. Neurology. 2011;76(10):911–917.
24. Danhelovska T, Kolarova H, Zeman J, et al. Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex I. BMC Pediatr. 2020;20(1):41.
25. Schoonen M, Smuts I, van der Westhuizen FH, et al. Panel-based nuclear and mitochondrial next-generation sequencing outcomes of an ethnically diverse pediatric patient cohort with mitochondrial disease. J Mol Diagn. 2019;21(3):503–513.
26. Riley LG, Cowley MJ, Gayevskiy V, et al. The diagnostic utility of genome sequencing in a pediatric cohort with suspected mitochondrial disease. Genet Med. 2020;22(7):1254–1261.
27. Tolomeo D, Rubegni A, Severino M, et al. The diagnostic approach to mitochondrial disorders in children in the era of next-generation sequencing: a 4-year cohort study. J Clin Med. 2021;10(15):3222.
28. Wong S, Napoli E, Krakowiak P, et al. Role of p53, mitochondrial DNA deletions, and paternal age in autism: a case-control study. Pediatrics. 2016;137(4):e20151888.
29. Varga NA, Pentelényi K, Gál A, et al. Mitochondrial dysfunction and autism: comprehensive genetic analyses of children with autism and mtDNA deletion. Behav Brain Funct. 2018;14(1):4.
30. Adiba F, Chowdhury MY, Rahman MM, et al. Mutational landscape of mitochondrial cytochrome b and its flanking tRNA genes associated with increased mitochondrial DNA copy number and disease risk in children with autism. Gene Rep. 2024;35:101895.
31. Alvarez-Iglesias V, Mosquera-Miguel A, Cuscó I, et al. Reassessing the role of mitochondrial DNA mutations in autism spectrum disorder. BMC Med Genet. 2011;12:50.
32. Hadjixenofontos A, Schmidt MA, Whitehead PL, et al. Evaluating mitochondrial DNA variation in autism spectrum disorders. Ann Hum Genet. 2013;77(1):9–21.
33. Weissman JR, Kelley RI, Bauman ML, et al. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One. 2008;3(11):e3815.
34. Lake NJ, Compton AG, Rahman S, et al. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol. 2016;79(2):190–203.
35. Sofou K, De Coo IFM, Isohanni P, et al. A multicenter study of Leigh syndrome: disease course and predictors of survival. Orphanet J Rare Dis. 2014;9:52.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Putu Rika Anjani, Erika Aini Putri S, dr. Iffa Maulida Wiedy Astari, dr. Yudi Wahyudi, Veriantara Satya Dhika
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
